These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 10471914)

  • 1. ArQule-Pfizer deal breaks mold.
    Dorey E
    Nat Biotechnol; 1999 Sep; 17(9):843-4. PubMed ID: 10471914
    [No Abstract]   [Full Text] [Related]  

  • 2. Ann Arbor community rallies in wake of Pfizer shutdown.
    Shaffer C
    Nat Biotechnol; 2007 Aug; 25(8):829-30. PubMed ID: 17687347
    [No Abstract]   [Full Text] [Related]  

  • 3. The view from the top.
    Howard K
    Nature; 2003 Dec; 426(6967):696-7. PubMed ID: 14668873
    [No Abstract]   [Full Text] [Related]  

  • 4. Job movements.
    Smaglik P
    Nature; 2005 Feb; 433(7028):901. PubMed ID: 15729349
    [No Abstract]   [Full Text] [Related]  

  • 5. Indian biogenerics industry emerges.
    Jayaraman KS
    Nat Biotechnol; 2003 Oct; 21(10):1115-6. PubMed ID: 14520378
    [No Abstract]   [Full Text] [Related]  

  • 6. Can complexity be commercialized?
    Mack GS
    Nat Biotechnol; 2004 Oct; 22(10):1223-9. PubMed ID: 15470456
    [No Abstract]   [Full Text] [Related]  

  • 7. Drugmakers seek gold in doc IT. What Pfizer, Merck see as needed services, critics tie to drug marketing.
    Romano M
    Mod Healthc; 2001 Oct; 31(44):6-7, 14. PubMed ID: 11715738
    [No Abstract]   [Full Text] [Related]  

  • 8. Market watch: sales trends by therapeutic area: 2008-2013E.
    Goodman M
    Nat Rev Drug Discov; 2009 Sep; 8(9):689. PubMed ID: 19721440
    [No Abstract]   [Full Text] [Related]  

  • 9. Sales from licensed and acquired products to increase by 2013.
    Goodman M
    Nat Rev Drug Discov; 2009 Jun; 8(6):443. PubMed ID: 19483704
    [No Abstract]   [Full Text] [Related]  

  • 10. [History of insecticides and the transition of their production and sales].
    Takayama C
    Chudoku Kenkyu; 2008 Apr; 21(2):123-31. PubMed ID: 18516936
    [No Abstract]   [Full Text] [Related]  

  • 11. [A peculiar advertisement].
    Jervell J
    Tidsskr Nor Laegeforen; 2004 Jul; 124(13-14):1823-4. PubMed ID: 15229680
    [No Abstract]   [Full Text] [Related]  

  • 12. Drug research--a change of paradigms.
    Müllner S
    Arzneimittelforschung; 1997 Jan; 47(1):105. PubMed ID: 9037454
    [No Abstract]   [Full Text] [Related]  

  • 13. Overcoming the challenges in the pharma/biotech industry.
    Graul AI; Prous JR
    Drug News Perspect; 2007; 20(1):57-68. PubMed ID: 17332900
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Public biotech 2008--the numbers.
    Huggett B; Hodgson J; Lähteenmäki R
    Nat Biotechnol; 2009 Aug; 27(8):710-21. PubMed ID: 19668175
    [TBL] [Abstract][Full Text] [Related]  

  • 15. What does R&D really cost?
    Huff B
    GMHC Treat Issues; 2001; 15(7-8):1-7. PubMed ID: 11548507
    [No Abstract]   [Full Text] [Related]  

  • 16. Drug price deal spells windfall for researchers.
    Bosch X
    Nature; 2001 Nov; 414(6860):138. PubMed ID: 11700514
    [No Abstract]   [Full Text] [Related]  

  • 17. Drug life-cycle technologies.
    Fleming E; Ma P
    Nat Rev Drug Discov; 2002 Oct; 1(10):751-2. PubMed ID: 12360253
    [No Abstract]   [Full Text] [Related]  

  • 18. Deals landscape: notable deals in the pharmaceutical industry in the third quarter of 2008.
    Glah D; Tear S
    IDrugs; 2008 Nov; 11(11):841-5. PubMed ID: 19024888
    [No Abstract]   [Full Text] [Related]  

  • 19. [Medical research--money or life?].
    Fretheim A; Sørbye IK
    Tidsskr Nor Laegeforen; 2003 Oct; 123(20):2908-9. PubMed ID: 14600724
    [No Abstract]   [Full Text] [Related]  

  • 20. GAO report says drug R & D costs rising, innovation decreasing.
    Consult Pharm; 2007 Mar; 22(3):257-8. PubMed ID: 17691159
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.